Aegerion Pharmaceuticals Holdings, Inc.
11
Martin Glenn
05/20/2019
05/28/2020
Yes
v
| JtAdm, CLMAGT, MEGA |
Assigned to: Judge Martin Glenn Chapter 11 Voluntary Asset |
|
Debtor Aegerion Pharmaceuticals Holdings, Inc.
245 First Street, Riverview II 18th Floor Cambridge, MA 02142 MIDDLESEX-MA Tax ID / EIN: 61-1721331 |
represented by |
Paul V. Shalhoub
Willkie Farr & Gallagher LLP 787 Seventh Avenue New York, NY 10019-6099 (212) 728-8764 Fax : (212) 728-8111 Email: maosbny@willkie.com |
U.S. Trustee United States Trustee
Office of the United States Trustee U.S. Federal Office Building 201 Varick Street, Room 1006 New York, NY 10014 (212) 510-0500 |
| |
Claims and Noticing Agent Prime Clerk LLC Claims Agent
One Grand Central Place 60 East 42nd Street, Suite 1440 www.primeclerk.com New York, NY 10165 (212) 257-5450 |
| Date Filed | # | Docket Text |
|---|---|---|
| 05/24/2019 | 7 | Transcript regarding Hearing Held on 05/23/19 At 9:04 AM RE: (Doc. No. 3) Motion For Joint Administration Filed By Paul V. Shalhoub On Behalf Of Aegerion Pharmaceuticals Holdings, Inc. Remote electronic access to the transcript is restricted until 8/22/2019. The transcript may be viewed at the Bankruptcy Court Clerks Office. [Transcription Service Agency: Veritext Legal Solutions.]. (See the Courts Website for contact information for the Transcription Service Agency.) (RE: related document(s) 3). Notice of Intent to Request Redaction Deadline Due By 5/31/2019. Statement of Redaction Request Due By 6/14/2019. Redacted Transcript Submission Due By 6/24/2019. Transcript access will be restricted through 8/22/2019. (Ramos, Jonathan) (Entered: 05/31/2019) |
| 05/24/2019 | Claims and Noticing Agent, Prime Clerk LLC , added to the case. (Richards, Beverly). (Entered: 05/24/2019) | |
| 05/24/2019 | An order has been entered in this case directing the procedural consolidation and joint administration of the chapter 11 cases of Aegerion Pharmaceuticals, Inc. and its affiliates that have concurrently commenced chapter 11 cases. The docket in the chapter 11 case of Aegerion Pharmaceuticals, Inc., Case No. 19-11632 (MG), should be consulted for all matters affecting this case. (Gomez, Jessica). (Entered: 05/24/2019) | |
| 05/24/2019 | 6 | Order signed on 5/24/2019 Granting Motion for Joint Administration of Related Chapter 11 Cases under Lead Case Number 19-11632(MG) Aegerion Pharmaceuticals, Inc. (Related Doc # 3). (Gomez, Jessica) (Entered: 05/24/2019) |
| 05/21/2019 | Judge Martin Glenn added to the case. (Porter, Minnie). (Entered: 05/21/2019) | |
| 05/21/2019 | 5 | Statement of Financial Affairs - Non-Individual Filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals Holdings, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) |
| 05/21/2019 | 4 | Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual Filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals Holdings, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) |
| 05/21/2019 | 3 | Motion for Joint Administration filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals Holdings, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) |
| 05/21/2019 | 2 | Declaration of John R. Castellano in Support of Chapter 11 Petitions and First Day Pleadings filed by Paul V. Shalhoub on behalf of Aegerion Pharmaceuticals Holdings, Inc.. (Shalhoub, Paul) (Entered: 05/21/2019) |
| 05/20/2019 | Receipt of Voluntary Petition (Chapter 11)( 19-11633) [misc,824] (1717.00) Filing Fee. Receipt number A13218205. Fee amount 1717.00. (Re: Doc # 1) (U.S. Treasury) (Entered: 05/20/2019) |